editor's Reviews

Welcome to IQVIA Scribe, an innovative online/offline application designed to facilitate data collection directly from patients participating in clinical trials. With IQVIA Scribe, patients enrolled in a study receive a user-friendly app that allows them to complete relevant questionnaires and provide valuable feedback throughout the study period. IQVIA is revolutionizing the way Clinical Outcomes Assessments are incorporated into trials, amplifying the patient's voice in the research process. By leveraging cutting-edge technologies and expertise in ePRO solutions, IQVIA ensures transparency and control for sponsors and CROs. This next-generation platform combines the convenience of mobile and web access with the efficiency of automated eCOA processes, empowering patients and streamlining data collection. Join us on this journey to transform clinical research with IQVIA Scribe!

Latest Update Enhanced Performance and Security Measures Implemented

IQVIA Scribe has recently introduced new features to enhance user experience and optimize data collection processes. The latest update includes improvements in app performance, bug fixes, and enhanced security measures to safeguard patient data. Users can expect a smoother and more efficient data capture process with the latest version of IQVIA Scribe.

Features

Secure online/offline data capture from enrolled patients

Seamless integration with Clinical Outcomes Assessments

User-friendly interface for easy questionnaire completion

Automated eCOA processes for data accuracy

Transparency and control for sponsors and CROs

Real-time feedback and monitoring capabilities

Multi-platform deployment (smartphones, tablets, web)

Next-generation solutions for efficient data collection

Positive Reviews

1. Empowers patients to provide valuable feedback

2. Enhances transparency and control for sponsors

3. Improves efficiency in data capture processes

4. User-friendly interface for easy navigation

Negatie Reviews

1. Requires patient enrollment in a clinical trial

2. Dependent on patient participation for data collection